Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 4/20 | 0.46 |
| ▸ | TYR | P14679 | 2/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.46 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | MIF | P14174 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 4/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 3/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | ATP2A2 | P16615 | 1/20 | 0.44 |
| ▸ | ATP2A3 | Q93084 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30041549 | 1.00 | ALDH1A1 (0.46) | ALDH1A1ALOX15TYRHSD17B10CYP2C9 | |
| SCHEMBL10906475 | 0.85 | CA2 (0.56) | ALDH1A1ALOX15TYRHSD17B10CYP2C9 | |
| SCHEMBL23542366 | 0.85 | ALDH1A1 (0.42) | ALDH1A1ALOX15TYRHSD17B10CYP2C9 | |
| Acrylic Acid SCHEMBL30343695 | 0.84 | TNFRSF1A (0.37) | ALDH1A1ALOX15TYRHSD17B10CYP2C9 | |
| Acrylic Acid SCHEMBL28546157 | 0.84 | TNFRSF1A (0.37) | ALDH1A1ALOX15TYRHSD17B10CYP2C9 | |
| SCHEMBL30048420 | 0.83 | ALDH1A1 (0.48) | ALDH1A1ALOX15TYRHSD17B10CYP2C9 | |
| SCHEMBL142313 | 0.83 | ALDH1A1 (0.48) | ALDH1A1ALOX15TYRHSD17B10CYP2C9 | |
| SCHEMBL8819969 | 0.82 | ALDH1A1 (0.42) | ALDH1A1ALOX15TYRHSD17B10CYP2C9 | |
| SCHEMBL10918867 | 0.81 | ALDH1A1 (0.35) | ALDH1A1ALOX15TYRHSD17B10CYP2C9 | |
| SCHEMBL30772983 | 0.81 | CA2 (0.52) | ALDH1A1ALOX15TYRHSD17B10CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 613 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260092030-A1 | IMPROVED PROCESS FOR PRODUCING HIGH-PURITY BUTYL ACRYLATE | ARKEMA FRANCE (FR) | 2026-04-02 | — | — | US | claimed |
| US-12590053-B2 | Process for preparing vanillin (meth)acrylates | EVONIK OPERATIONS GMBH (DE) | 2026-03-31 | — | — | US | claimed |
| EP-4211106-B1 | A PROCESS FOR PREPARING VANILLIN (METH)ACRYLATES | EVONIK OPERATIONS GMBH (DE) | 2025-11-19 | — | — | EP | claimed |
| EP-4605370-A1 | IMPROVED PROCESS FOR PRODUCING HIGH-PURITY BUTYL ACRYLATE | ARKEMA France (FR) | 2025-08-27 | — | — | EP | claimed |
| US-20250236584-A1 | IMPROVED METHOD FOR PRODUCING HIGH-PURITY BUTYL ACRYLATE | ARKEMA FRANCE (FR) | 2025-07-24 | — | — | US | claimed |
| EP-4423053-A1 | IMPROVED METHOD FOR PRODUCING HIGH-PURITY BUTYL ACRYLATE | ARKEMA FRANCE (FR) | 2024-09-04 | — | — | EP | claimed |
| CN-118139838-A | Improved process for producing high purity butyl acrylate | 阿科玛法国公司 | 2024-06-04 | — | — | CN | claimed |
| WO-2024084149-A1 | IMPROVED PROCESS FOR PRODUCING HIGH-PURITY BUTYL ACRYLATE | ARKEMA FRANCE (FR) | 2024-04-25 | — | — | WO | claimed |
| CN-114829478-B | Elastomer composition reinforced by ground biochar | 米其林集团总公司 | 2024-04-16 | — | — | CN | claimed |
| US-20230365487-A1 | A PROCESS FOR PREPARING VANILLIN (METH)ACRYLATES | EVONIK OPERATIONS GMBH (DE) | 2023-11-16 | — | — | US | claimed |
| US-5637689-A | CATALYZING IN PRESENCE A MIXTURE OF CALCIUM CHELATE AND A TIN COMPOUND | ELF ATOCHEM S.A. (FR) | 1997-06-10 | — | — | US | claimed |
| US-5610313-A | Process for the preparation of alkylimidazolidone (meth) acrylates | ELF ATOCHEM S.A. (FR) | 1997-03-11 | — | — | US | claimed |
| US-5585514-A | ADDING NON-AROMATIC 1,2-DIAMINE TO REACTION MIXTURE BEFORE DISTILLATION TO REACT WITH BIACETYL BY-PRODUCT | ELF ATOCHEM S.A. (FR) | 1996-12-17 | — | — | US | claimed |
| US-5498723-A | REACTING ACRYLATE WITH HETEROCYCLIC ALCOHOL | ELF ATOCHEM S.A. (FR) | 1996-03-12 | — | — | US | claimed |
| US-5481012-A | REACTION OF HYDROGEN PEROXIDE WITH DOUBLE BOND | ATOCHEM (FR) | 1996-01-02 | — | — | US | claimed |
| EP-0433135-B1 | Process for the preparation of alkylimidazolidone (meth)acrylate | ATOCHEM ELF SA (FR) | 1995-02-15 | — | — | EP | claimed |
| CN-1097742-A | The method for preparing alkyl imidazoline ketone (methyl) acrylate | ATOCHEM ELF SA (FR) | 1995-01-25 | — | — | CN | claimed |
| US-5210199-A | PROCESS FOR THE PREPARATION OF ALKYLIMIDAZOLIDONE (METH) ACRYLATE | ATOCHEM (FR) | 1993-05-11 | — | — | US | claimed |
| US-4530770-A | Oxidation resistance | MOBIL OIL CORPORATION (US) | 1985-07-23 | — | — | US | claimed |
| US-4323714-A | Alkylation of hydroxy-substituted aromatic compounds | UOP INC. (US) | 1982-04-06 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230365487-A1 | A PROCESS FOR PREPARING VANILLIN (METH)ACRYLATES | VCL, ACR, VARS1 | ALDH1A1 53/4885ALOX15 3341/4885TYR 22/4885 |
| US-20260092030-A1 | IMPROVED PROCESS FOR PRODUCING HIGH-PURITY BUTYL ACRYLATE | ACR, ADH1C, RTCB | ALDH1A1 50/4885ALOX15 1500/4885TYR 2634/4885 |
| US-12590053-B2 | Process for preparing vanillin (meth)acrylates | ADH1A, HVCN1, ADH1C | ALDH1A1 197/4885ALOX15 4446/4885TYR 494/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.